Skip to main navigation
Skip to search
Skip to main content
Status Active Effective start/end date 6/15/22 → 4/30/27
HHS: National Institutes of Health (NIH): $2,423,959.00
Transient Receptor Potential Vanilloid 1 (TRPV1)
Keyphrases
100%
Polymodal
Keyphrases
100%
Vanilloid Receptor 1 Antagonist
Pharmacology, Toxicology and Pharmaceutical Science
100%
Clinical Trial
Pharmacology, Toxicology and Pharmaceutical Science
100%
TRPV1
Biochemistry, Genetics and Molecular Biology
100%
Capsaicin
Pharmacology, Toxicology and Pharmaceutical Science
50%
Vanilloids
Pharmacology, Toxicology and Pharmaceutical Science
50%
Analgesic Agent
Pharmacology, Toxicology and Pharmaceutical Science
50%